Sunday, April 3, 2016

BRIEF-Novo says Victoza reduces glycated haemoglobin more than sitagliptin

* Says Victoza provided superior HbA1c reductions in adults with type 2 diabetes compared to continued sitagliptin treatment











Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)